Literature DB >> 22138071

Controlled release of a highly hydrophilic API from lipid microspheres obtained by prilling: analysis of drug and water diffusion processes with X-ray-based methods.

Perrine Pivette1, Vincent Faivre, Lucia Mancini, Claire Gueutin, Georges Daste, Michel Ollivon, Sylviane Lesieur.   

Abstract

This study deals with the development of an oral controlled-release dosage form of a highly water-soluble antiepileptic drug. In this respect, drug-loaded spheroid particles close to 380 μm in diameter and composed of lipid binders were prepared by prilling. The purpose here was to thoroughly characterize the controlled-release mechanism of the drug in aqueous pH-6.8 buffered dissolution medium. Water and drug diffusion pathways as well as related kinetic parameters were determined by theoretical analysis of experimental data. Conventional in-vitro experiments performed by analytical high performance liquid chromatography showed that the released fraction reaches 90 wt.% only after a 24-hour immersion in the dissolution medium, pointing out an effective sustained release mechanism. Interpretation of these data was strengthened by the implementation of an innovative methodology involving X-ray diffraction and microtomography to follow the structural evolution of the drug-loaded microspheres at molecular and microscopic scales. This approach allowed to explicit that water and drug transports obey to Fickian diffusion behaviours in good agreement with Crank's and non-simplified Higuchi's equations, respectively. In the latter case, independent modelling of drug release assimilating the microspheres to a variable-geometry reservoir was considered to refine the kinetic analysis of the diffusion process. The water diffusion coefficient D(w) was found equal to 6.3 × 10(-9) cm(2)/s and the API apparent diffusion coefficient reduced to the tortuosity of the matrix D(API)/τ equal to 2 × 10(-9) cm(2)/s. This study ranks among the rare examples of monolithic dispersion device constituted by a highly soluble drug incorporated inside a perfectly inert lipid matrix. The dissolution liquid penetrates the particles through channels progressively created by the solubilization of the drug itself which occurs instantaneously at the inner front of the liquid.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138071     DOI: 10.1016/j.jconrel.2011.11.027

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

1.  Release behaviour of single pellets and internal fine 3D structural features co-define the in vitro drug release profile.

Authors:  Shuo Yang; Xianzhen Yin; Caifen Wang; Haiyan Li; You He; Tiqiao Xiao; Lixin Sun; Jiasheng Li; Peter York; Jun He; Jiwen Zhang
Journal:  AAPS J       Date:  2014-05-30       Impact factor: 4.009

2.  Sucrose stearate-enriched lipid matrix tablets of etodolac: modulation of drug release, diffusional modeling and structure elucidation studies.

Authors:  Ahmed Abd-Elbary; Mina Ibrahim Tadros; Ahmed Adel Alaa-Eldin
Journal:  AAPS PharmSciTech       Date:  2013-04-10       Impact factor: 3.246

Review 3.  Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.

Authors:  Karin Becker; Sharareh Salar-Behzadi; Andreas Zimmer
Journal:  Pharm Res       Date:  2015-03-19       Impact factor: 4.200

4.  Three dimensional distribution of surfactant in microspheres revealed by synchrotron radiation X-ray microcomputed tomography.

Authors:  Li Wu; Manli Wang; Vikramjeet Singh; Haiyan Li; Zhen Guo; Shuangying Gui; Peter York; Tiqiao Xiao; Xianzhen Yin; Jiwen Zhang
Journal:  Asian J Pharm Sci       Date:  2017-02-15       Impact factor: 6.598

5.  Synchrotron radiation-based Fourier-transform infrared spectromicroscopy for characterization of the protein/peptide distribution in single microspheres.

Authors:  Manli Wang; Xiaolong Lu; Xianzhen Yin; Yajun Tong; Weiwei Peng; Li Wu; Haiyan Li; Yan Yang; Jingkai Gu; Tiqiao Xiao; Min Chen; Jiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2015-04-14       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.